Showing 681 - 700 results of 1,381 for search '(( significant decrease decrease ) OR ( significant anti decrease ))~', query time: 0.41s Refine Results
  1. 681

    <b>ART does not correct plasma virome and cytokine dysregulations induced by HIV-1</b> by Yingying Ma (18762652)

    Published 2024
    “…Notably, most cytokines dysregulated were not fully restored by ART, with abnormal levels of IL-10, GM-CSF, VEGF, and eotaxin, and a significantly increased level of plasma I-FABP. Anelloviruses showed significantly negative correlations with other commensal viruses except HPgV-1, but had positive corrections with several anti-inflammatory and Th1 cytokines.…”
  2. 682

    Image 1_Epimedium brevicornu Maxim. extract activates natural killer cells against hepatocellular carcinoma via the cGAS-STING pathway.tif by Lu Liu (171341)

    Published 2025
    “…., a traditional Chinese botanical drug, has shown significant therapeutic effects against hepatocellular carcinoma (HCC), with its flavonoid compounds exhibiting anti-HCC activity through various mechanisms. …”
  3. 683
  4. 684
  5. 685
  6. 686
  7. 687

    Critical period EB odorant experience via Or42a neurons specifically elevates VM7 serotonin signaling. by Vanessa Kay Miller (19775496)

    Published 2024
    “…Two-way ANOVA with Tukey’s multiple comparisons show a significant increase in serotonin (<i>n</i> = 12/condition, <i>p</i> = 7.13 × 10<sup>−5</sup>) and a significant decrease in VM7 innervation (<i>n</i> = 12/condition, <i>p</i> = 4.78 × 10<sup>−10</sup>) with EB experience. …”
  8. 688

    Table 1_The association between Dietary Index for Gut Microbiota and sarcopenia: the mediating role of Dietary Inflammatory Index.docx by Hongyang Gong (19561855)

    Published 2025
    “…RCS analysis revealed a significant linear relationship between DI-GM and sarcopenia. …”
  9. 689

    Data Sheet 1_Dupilumab treatment has no effect on the nasal microbiome in patients with NSAID-exacerbated respiratory disease: a longitudinal pilot study.pdf by Tina Bartosik (12300785)

    Published 2025
    “…Background<p>Non-steroidal anti-inflammatory drugs-exacerbated respiratory disease (N-ERD) affects up to 10% of patients suffering from nasal polyps and has a severe impact on quality of life. …”
  10. 690

    Table 1_PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients.docx by Ana Virseda-Berdices (9638081)

    Published 2025
    “…</p>Methods<p>We performed a retrospective study in 48 HIV/HCV-coinfected patients who started anti-HCV treatment with at least advanced fibrosis (LSM ≥9.5). …”
  11. 691

    Data Sheet 1_PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients.docx by Ana Virseda-Berdices (9638081)

    Published 2025
    “…</p>Methods<p>We performed a retrospective study in 48 HIV/HCV-coinfected patients who started anti-HCV treatment with at least advanced fibrosis (LSM ≥9.5). …”
  12. 692

    Table 2_PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients.docx by Ana Virseda-Berdices (9638081)

    Published 2025
    “…</p>Methods<p>We performed a retrospective study in 48 HIV/HCV-coinfected patients who started anti-HCV treatment with at least advanced fibrosis (LSM ≥9.5). …”
  13. 693

    Table 4_PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients.docx by Ana Virseda-Berdices (9638081)

    Published 2025
    “…</p>Methods<p>We performed a retrospective study in 48 HIV/HCV-coinfected patients who started anti-HCV treatment with at least advanced fibrosis (LSM ≥9.5). …”
  14. 694

    Table 3_PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients.docx by Ana Virseda-Berdices (9638081)

    Published 2025
    “…</p>Methods<p>We performed a retrospective study in 48 HIV/HCV-coinfected patients who started anti-HCV treatment with at least advanced fibrosis (LSM ≥9.5). …”
  15. 695

    Image 1_PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients.pdf by Ana Virseda-Berdices (9638081)

    Published 2025
    “…</p>Methods<p>We performed a retrospective study in 48 HIV/HCV-coinfected patients who started anti-HCV treatment with at least advanced fibrosis (LSM ≥9.5). …”
  16. 696

    Supplementary file 1_Protective effects and mechanism of resveratrol in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis.docx by Yajie Yin (10115902)

    Published 2025
    “…Improved fibrosis: significant reduction in pulmonary fibrosis score (SMD = −2.30, 95% CI [−2.80, −1.79], p < 0.00001, I<sup>2</sup> = 76%) and decreased Hyp content (SMD = −2.16, 95% CI [−2.69, −1.63], p < 0.00001, I<sup>2</sup> = 85%); 2. …”
  17. 697

    Image 1_Myristic acid beneficially modulates intervertebral disc degeneration by preventing endplate osteochondral remodeling and vertebral osteoporosis in naturally aged mice.pdf by Yan Gong (103494)

    Published 2025
    “…Additionally, MA notably inhibited osteoclast activity, as evidenced by a decrease in the number of osteoclasts and a significant suppression of F-actin formation. …”
  18. 698

    Co-immunoprecipitation and BiFC experiments related to Abd-B and Exd interaction. by Jesús R. Curt (20553231)

    Published 2025
    “…Protein present in the co-IPs is indicated above the gels. There is a significant decrease in the amount of the Abd-B<sup>W</sup> protein captured on the resin when compared to the Abd-B wildtype protein (24%), while Exd remains almost unchanged (2%). …”
  19. 699

    Image 4_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.tif by Daniel E. Millian (20296458)

    Published 2025
    “…In parallel, spectral imaging further revealed post-treatment shifts in macrophage populations, with a significant decrease in inflammatory subsets (CD14+, CD14+/Mac387+, p<0.05) and an increase in anti-inflammatory subsets (CD16+, CD16+/CD163+, CD16+/CD68+, p<0.05). …”
  20. 700

    Image 2_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.tif by Daniel E. Millian (20296458)

    Published 2025
    “…In parallel, spectral imaging further revealed post-treatment shifts in macrophage populations, with a significant decrease in inflammatory subsets (CD14+, CD14+/Mac387+, p<0.05) and an increase in anti-inflammatory subsets (CD16+, CD16+/CD163+, CD16+/CD68+, p<0.05). …”